{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:52:30Z","timestamp":1767135150389,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd012756","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000}}],"reference-count":77,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012756.pub2","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T10:08:59Z","timestamp":1625479739000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bisphosphonate use in children with cerebral palsy"],"prefix":"10.1002","volume":"2021","author":[{"given":"Tim","family":"Hurley","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; Trinity College Dublin; Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunera","family":"Zareen","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; Trinity College Dublin; Dublin Ireland"},{"name":"Department of Paediatrics; The National Children\u2019s Hospital; Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; The National Children\u2019s Hospital; Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciara","family":"McDonnell","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology & Diabetes; The National Children\u2019s Hospital, Tallaght; Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"McDonald","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; The National Children\u2019s Hospital; Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Molloy","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; Trinity College Dublin; Dublin Ireland"},{"name":"Department of Paediatrics; The National Children\u2019s Hospital; Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,7,5]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD012756.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1067\/mpd.2002.128207","article-title":"Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial","volume":"141","author":"Henderson","year":"2002","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD012756.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1442-200X.2008.02571.x","article-title":"Secondary osteoporosis in long-term bedridden patients with cerebral palsy","volume":"50","author":"Iwasaki","year":"2008","journal-title":"Pediatrics international"},{"issue":"1","key":"10.1002\/14651858.CD012756.pub2-BIB0003|cit3","first-page":"91","article-title":"Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study","volume":"71","author":"Allington","year":"2005","journal-title":"Acta Orthopaedica Belgica"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD012756.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"S228","DOI":"10.1016\/S8756-3282(01)00454-9","article-title":"The use of pamidronate to treat osteoporosis in children with spastic quadriplegic cerebral palsy and recurrent fractures","volume":"28","author":"Bachrach","year":"2001","journal-title":"Bone"},{"issue":"4 Part 2","key":"10.1002\/14651858.CD012756.pub2-BIB0005|cit5","first-page":"69A","article-title":"Treatment of osteoporosis with pamidronate in children with spastic quadriplegic cerebral palsy and recurrent fractures","volume":"53","author":"Bachrach","year":"2003","journal-title":"Pediatric Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012756.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"S1891","DOI":"10.1093\/edrv\/31.supp.s1","article-title":"Effects of pamidronate treatment in non-ambulatory children with spastic quadriplegia and other neuromuscular disorders","volume":"31","author":"Bowden","year":"2010","journal-title":"Endocrine Reviews"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012756.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1159\/000481424","article-title":"The bone metabolism in pediatric patients with cerebral palsy","volume":"88","author":"Brad","year":"2017","journal-title":"Hormone Research in Paediatrics"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012756.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000239668","article-title":"Low dose pamidronate improve bone mineral density in children with cerebral palsy","volume":"72","author":"Brunetto","year":"2009","journal-title":"Hormone Research"},{"issue":"2","key":"10.1002\/14651858.CD012756.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/PRM-130242","article-title":"Oral risedronate sodium improves bone mineral density in non-ambulatory patients: a randomized, double-blind, placebo controlled trial","volume":"6","author":"Cohran","year":"2013","journal-title":"Journal of Pediatric Rehabilitation Medicine"},{"key":"10.1002\/14651858.CD012756.pub2-BIB0010|cit10","unstructured":"Oral alendronate for osteoporosis treatment in non-walking children with cerebral palsy www.clinicaltrialsregister.eu\/ctr-search\/trial\/2006-005678-36\/FR"},{"issue":"9","key":"10.1002\/14651858.CD012756.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1017\/S0012162206001514","article-title":"Low doses of pamidronate for the treatment of osteopenia in non-ambulatory children","volume":"48","author":"Henderson","year":"2006","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"7","key":"10.1002\/14651858.CD012756.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1097\/BPO.0b013e3182a11d0c","article-title":"Prevention of postoperative osteopenia using IV pamidronate: a pilot study","volume":"33","author":"Hobby","year":"2013","journal-title":"Journal of Pediatric Orthopaedics"},{"issue":"1","key":"10.1002\/14651858.CD012756.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/17518420903236270","article-title":"Pamidronate improves pain, wellbeing, fracture rate and bone density in 14 children and adolescents with chronic neurological conditions","volume":"13","author":"Howe","year":"2010","journal-title":"Developmental Neurorehabilitation"},{"issue":"5","key":"10.1002\/14651858.CD012756.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1185\/03007995.2011.645562","article-title":"Long-term outcomes of children and adolescents who had cerebral palsy with secondary osteoporosis","volume":"28","author":"Iwasaki","year":"2012","journal-title":"Current Medical Research and Opinion"},{"issue":"2","key":"10.1002\/14651858.CD012756.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.17816\/PTORS33961","article-title":"Bone mineral density in children with cerebral palsy and spina bifida treated with ibandronate","volume":"8","author":"Kenis","year":"2020","journal-title":"Pediatric Traumatology, Orthopaedics and Reconstructive Surgery"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012756.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000239668","article-title":"Decreased fracture rate and bone turnover after pamidronate infusion in children with cerebral palsy and severe osteoporosis","volume":"72","author":"Marchand","year":"2009","journal-title":"Hormone Research"},{"issue":"12","key":"10.1002\/14651858.CD012756.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3345\/kjp.2017.60.12.403","article-title":"The effect of low-dose intravenous bisphosphonate treatment on osteoporosis in children with quadriplegic cerebral palsy","volume":"60","author":"Moon","year":"2017","journal-title":"Korean Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD012756.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/sj.sc.3101725","article-title":"Effect of alendronate on bone mineral density in spinal cord injury patients: a pilot study","volume":"43","author":"Moran De Brito","year":"2005","journal-title":"Spinal Cord"},{"key":"10.1002\/14651858.CD012756.pub2-BIB0019|cit19","unstructured":"Prevention of post operative bone loss in children clinicaltrials.gov\/ct2\/show\/NCT00655681"},{"key":"10.1002\/14651858.CD012756.pub2-BIB0020|cit20","unstructured":"Use of oral bisphosphonates in the treatment of osteoporosis of non-walking children with cerebral palsy clinicaltrials.gov\/ct2\/show\/NCT00822029"},{"issue":"12","key":"10.1002\/14651858.CD012756.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/adc.2007.129692","article-title":"Radiological findings in cyclical administration of intravenous pamidronate in children with osteoporosis","volume":"92","author":"Onwuneme","year":"2007","journal-title":"Archives of Disease in Childhood"},{"issue":"2","key":"10.1002\/14651858.CD012756.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00381-011-1576-9","article-title":"Osteopenia in children with cerebral palsy can be treated with oral alendronate","volume":"28","author":"Paksu","year":"2012","journal-title":"Child's Nervous System"},{"key":"10.1002\/14651858.CD012756.pub2-BIB0023|cit23","doi-asserted-by":"crossref","unstructured":"Erratum Developmental Medicine & Child Neurology 2006 48 12 1024. Erratum for: Developmental Medicine & Child Neurology 2006 Sep;48(9)709 12. DOI: 10.1017\/S0012162206001526 10.1017\/S0012162206002246","DOI":"10.1017\/S0012162206002246"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012756.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"S280","DOI":"10.1002\/jbmr.5650201302","article-title":"Low doses of pamidronate for the treatment of osteoporosis in children with cerebral palsy","volume":"20","author":"Plotkin","year":"2005","journal-title":"Journal of Bone and Mineral Research"},{"issue":"9","key":"10.1002\/14651858.CD012756.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1017\/S0012162206001526","article-title":"Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study","volume":"48","author":"Plotkin","year":"2006","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"5","key":"10.1002\/14651858.CD012756.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/STROKEAHA.106.474262","article-title":"A single infusion of zoledronate prevents bone loss after stroke","volume":"38","author":"Poole","year":"2007","journal-title":"Stroke"},{"issue":"8","key":"10.1002\/14651858.CD012756.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1210\/jc.2009-2814","article-title":"Risk of corrected QT interval prolongation after pamidronate infusion in children","volume":"95","author":"Rothenbuhler","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD012756.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/BPO.0000000000000421","article-title":"Pamidronate treatment to prevent reoccurring fractures in children with cerebral palsy","volume":"36","author":"Sees","year":"2016","journal-title":"Journal of Pediatric Orthopedics"},{"issue":"3","key":"10.1002\/14651858.CD012756.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/adc.71.3.235","article-title":"Osteopenia in cerebral palsy","volume":"71","author":"Shaw","year":"1994","journal-title":"Archives of Disease in Childhood"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012756.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/S1090-3798%2811%2970255-0","article-title":"Osteopenia in children with cerebral palsy can be treated with oral alendronate","volume":"15","author":"Vurucu","year":"2011","journal-title":"European Journal of Paediatric Neurology"},{"issue":"4","key":"10.1002\/14651858.CD012756.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00223-018-0505-2","article-title":"Annual injection of zoledronic acid improves bone status in children with cerebral palsy and Rett syndrome","volume":"104","author":"Wiedemann","year":"2019","journal-title":"Calcified Tissue International"},{"key":"10.1002\/14651858.CD012756.pub2-BIB0032|cit32","doi-asserted-by":"crossref","unstructured":"Errata Journal of Clinical Endocrinology & Metabolism 2013 98 1 420: Erratum for: Journal of Clinical Endocrinology & Metabolism. 2011 Oct; 96(10):3160 9. DOI: 10.1210\/jc.2011-1111 10.1210\/jc.2012-3878","DOI":"10.1210\/jc.2011-1111"},{"key":"10.1002\/14651858.CD012756.pub2-BIB0033|cit33","doi-asserted-by":"crossref","DOI":"10.1002\/9780470743386","volume-title":"Introduction to Meta-Analysis","author":"Borenstein","year":"2009"},{"issue":"5","key":"10.1002\/14651858.CD012756.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"427\u201336","DOI":"10.1016\/j.pmrj.2013.10.009","article-title":"Bisphosphonate treatment for children with disabling conditions","volume":"6","author":"Boyce","year":"2014","journal-title":"PM & R: The Journal of Injury, Function, and Rehabilitation"},{"issue":"1","key":"10.1002\/14651858.CD012756.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000447425","article-title":"A subtrochanteric femoral stress fracture following bisphosphonate treatment in an adolescent girl","volume":"87","author":"Boyce","year":"2017","journal-title":"Hormone Research in Paediatrics"},{"key":"10.1002\/14651858.CD012756.pub2-BIB0036|cit36","unstructured":"Deeks JJ Higgins JPT Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020 Available from www.training.cochrane.org\/handbook"},{"issue":"7","key":"10.1002\/14651858.CD012756.pub2-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005088.pub3","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","author":"Dwan","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7119","key":"10.1002\/14651858.CD012756.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1371\u20134","DOI":"10.1136\/bmj.315.7119.1371","article-title":"Meta-analysis: potentials and promise","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD012756.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1469-8749.2011.04091.x","article-title":"Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: a systematic review","volume":"54","author":"Fehlings","year":"2012","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"11","key":"10.1002\/14651858.CD012756.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1210\/jc.2015-2680","article-title":"Short-term safety of zoledronic acid in young patients with bone disorders: an extensive institutional experience","volume":"100","author":"George","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD012756.pub2-BIB0041|cit41","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2020"},{"key":"10.1002\/14651858.CD012756.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"924\u20136","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"12","key":"10.1002\/14651858.CD012756.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"1283\u201393","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence \u2014 imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012756.pub2-BIB0044|cit44","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD012756.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012756.pub2-BIB0046|cit46","unstructured":"Higgins JPT Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD012756.pub2-BIB0047|cit47","unstructured":"Higgins JPT Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020 Available from www.training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD012756.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1542\/peds.2009-0292","article-title":"Systematic review of interventions for low bone mineral density in children with cerebral palsy","volume":"125","author":"Hough","year":"2010","journal-title":"Paediatrics"},{"issue":"8","key":"10.1002\/14651858.CD012756.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1185\/03007995.2011.645562","article-title":"Long-term outcomes of children and adolescents who had cerebral palsy with secondary osteoporosis","volume":"28","author":"Iwasaki","year":"2012","journal-title":"Current Medical Research and Opinion"},{"issue":"10","key":"10.1002\/14651858.CD012756.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"Journal of Bone and Mineral Research"},{"issue":"11-12","key":"10.1002\/14651858.CD012756.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1515\/jpem-2014-0527","article-title":"Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis","volume":"28","author":"Kim","year":"2015","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD012756.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.6065\/apem.2020.25.1.15","article-title":"Bone health in pediatric patients with neurological disorders","volume":"25","author":"Ko","year":"2020","journal-title":"Annals of Pediatric Endocrinology & Metabolism"},{"issue":"10","key":"10.1002\/14651858.CD012756.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"773\u20138","DOI":"10.1111\/j.1469-8749.2009.03384.x","article-title":"Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy: a systematic review","volume":"51","author":"Mergler","year":"2009","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"7","key":"10.1002\/14651858.CD012756.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012756.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00198-019-05227-9","article-title":"Intravenous bisphosphonate therapy in children with spinal muscular atrophy","volume":"31","author":"Nasomyont","year":"2020","journal-title":"Osteoporosis International"},{"issue":"6","key":"10.1002\/14651858.CD012756.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","author":"National Institutes of Health Consensus Development Panel on Osteoporosis Prevention","year":"2001","journal-title":"JAMA"},{"issue":"9","key":"10.1002\/14651858.CD012756.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/dmcn.13196","article-title":"Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: an update","volume":"58","author":"Ozel","year":"2016","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"10","key":"10.1002\/14651858.CD012756.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/ptj\/80.10.974","article-title":"Validation of a model of gross motor function for children with cerebral palsy","volume":"80","author":"Palisano","year":"2000","journal-title":"Physical Therapy"},{"issue":"1","key":"10.1002\/14651858.CD012756.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1136\/fn.79.1.F21","article-title":"Epidemiology of cerebral palsy in England and Scotland, 1984\u20139","volume":"79","author":"Pharoah","year":"1998","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"1","key":"10.1002\/14651858.CD012756.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0004-9514(14)60183-5","article-title":"The epidemiology and causes of cerebral palsy","volume":"49","author":"Reddihough","year":"2003","journal-title":"Australian Journal of Physiotherapy"},{"issue":"11","key":"10.1002\/14651858.CD012756.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/j.1469-8749.2011.04044.x","article-title":"Using the Gross Motor Function Classification System to describe patterns of motor severity in cerebral palsy","volume":"53","author":"Reid","year":"2011","journal-title":"Developmental Medicine & Child Neurology"},{"key":"10.1002\/14651858.CD012756.pub2-BIB0062|cit62","unstructured":"Review Manager 5 (RevMan 5) The Cochrane Collaboration 2020"},{"issue":"1","key":"10.1002\/14651858.CD012756.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"issue":"1","key":"10.1002\/14651858.CD012756.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/dmcn.12865","article-title":"Decreasing prevalence in cerebral palsy: a multi-site European population-based study, 1980 to 2003","volume":"58","author":"Sellier","year":"2016","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"1","key":"10.1002\/14651858.CD012756.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"Journal of Bone and Mineral Research"},{"issue":"3","key":"10.1002\/14651858.CD012756.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jpc.13768","article-title":"Consensus guidelines on the use of bisphosphonate therapy in children and adolescents","volume":"54","author":"Simm","year":"2018","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"12","key":"10.1002\/14651858.CD012756.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/j.1469-8749.2008.03180.x","article-title":"Cerebral palsy and newborn care: I, II, and III (1981)","volume":"50","author":"Stanley","year":"2008","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"5","key":"10.1002\/14651858.CD012756.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fped.2017.00021","article-title":"Cerebral palsy \u2014 trends in epidemiology and recent development in prenatal mechanisms of disease, treatment, and prevention","volume":"13","author":"Stavsky","year":"2017","journal-title":"Frontiers in Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD012756.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/13638490600668061","article-title":"Fracture rate in children with cerebral palsy","volume":"9","author":"Stevenson","year":"2006","journal-title":"Paediatric Rehabilitation"},{"issue":"2","key":"10.1002\/14651858.CD012756.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/ddrr.18","article-title":"Gastrointestinal disorders in children with neurodevelopmental disabilities","volume":"14","author":"Sullivan","year":"2008","journal-title":"Developmental Disabilities Research Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012756.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/cen.14052","article-title":"Longitudinal changes in bone density in adolescents and young adults with cerebral palsy: a case for early intervention","volume":"91","author":"Trinh","year":"2019","journal-title":"Clinical Endocrinology"},{"issue":"9","key":"10.1002\/14651858.CD012756.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/dmcn.12178","article-title":"Fractures in children with cerebral palsy: a total population study","volume":"55","author":"Uddenfeldt Wort","year":"2013","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"10","key":"10.1002\/14651858.CD012756.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.3390\/ijms20102557","article-title":"Molecular-based treatment strategies for osteoporosis: a literature review","volume":"20","author":"Ukon","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1002\/14651858.CD012756.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety","volume":"30","author":"Vahle","year":"2002","journal-title":"Toxicologic Pathology"},{"issue":"4","key":"10.1002\/14651858.CD012756.pub2-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005324.pub2","article-title":"Bisphosphonate therapy for children and adolescents with secondary osteoporosis","author":"Ward","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD012756.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1210\/jc.2011-1111","article-title":"Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study","volume":"96","author":"Zemel","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"8","key":"10.1002\/14651858.CD012756.pub2-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012756","article-title":"Bisphosphonate use in children with cerebral palsy","author":"Zareen","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:02:46Z","timestamp":1760130166000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012756.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Developmental, Psychosocial and Learning Problems Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,5]]},"references-count":77,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012756.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,5]]}}}